Human IgG antibody Laboratories manufactures the zeptometrix mrsa controls reagents distributed by Genprice. The Zeptometrix Mrsa Controls reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Zeptometrix. Other Zeptometrix products are available in stock. Specificity: Zeptometrix Category: Mrsa Group: Controls
NATtrol MRSA/SA Negative Control (6 X 0.5 mL) |
|||
NATMSSE-6MC | Zeptometrix | 6 X 0.5 mL | EUR 307.92 |
|
|||
Description: Please contact Gentaur in order to receive the datasheet of the product. |
NATtrol MRSA/SA Negative Control (6 X 0.5 mL) |
|||
MDZ060 | Zeptometrix | 6 X 0.5 mL | EUR 315.2 |
|
|||
Description: Please contact Gentaur in order to receive the datasheet of the product. |
Zika IgM/IgG Control Pack (IgM,IgG & Negative Controls, 0.25mL) |
|||
0801020 | Zeptometrix | 0.25mL | EUR 102 |
|
|||
Description: Please contact Gentaur in order to receive the datasheet of the product. |
MRSA Antibody |
|||
abx022058-05mg | Abbexa | 0.5 mg | EUR 940 |
|
Spoligotyping Kit with Primers and Controls |
|||
IM9701 | Mapmygenome | EUR 1350 | |
Description: A very simple, inexpensive and effective tool for Tuberculosis/ Mycobacterium research. Spoligotyping is a PCR-based Method to Simultaneously Detect and Type Mycobacterium Tuberculosis Complex Bacteria. Spoligotyping, which uses RLB (Reversed Line Blotting) offers an alternative for typical Southern blotting when rapid results are required. The method is particularly useful to simultaneously detect and type M. tuberculosis complex bacteria in clinical samples (suspected nosocomial infections, outbreaks in prisons, etc.). The level of differentiation by spoligotyping is less compared to IS6110 fingerprinting for strains having five or more IS6110 copies, but higher for strains with less than five copies. Thus, Spoligotyping is a preferred method to type M. bovis strains, which usually contain only one or two IS6110 copies. Note, that Mycobacterium bovis can be recognized by the absence of reactivity with spacers 39-43. |
Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423) Antibody |
|||
BNUB0229-100 | Biotium | 100uL | EUR 209 |
Description: Primary antibody against Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423), Concentration: 0.2mg/mL |
Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423) Antibody |
|||
BNUB0229-500 | Biotium | 500uL | EUR 458 |
Description: Primary antibody against Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423), Concentration: 0.2mg/mL |
Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423) Antibody |
|||
BNUM0229-50 | Biotium | 50uL | EUR 395 |
Description: Primary antibody against Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423), 1mg/mL |
Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423) Antibody |
|||
BNC040229-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423),CF405S conjugate, Concentration: 0.1mg/mL |
Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423) Antibody |
|||
BNC040229-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423),CF405S conjugate, Concentration: 0.1mg/mL |
Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423) Antibody |
|||
BNC610229-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423),CF660R conjugate, Concentration: 0.1mg/mL |
Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423) Antibody |
|||
BNC610229-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423),CF660R conjugate, Concentration: 0.1mg/mL |
Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423) Antibody |
|||
BNC470229-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423),CF647 conjugate, Concentration: 0.1mg/mL |
Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423) Antibody |
|||
BNC470229-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423),CF647 conjugate, Concentration: 0.1mg/mL |
Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423) Antibody |
|||
BNC550229-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423),CF555 conjugate, Concentration: 0.1mg/mL |
Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423) Antibody |
|||
BNC550229-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423),CF555 conjugate, Concentration: 0.1mg/mL |
Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423) Antibody |
|||
BNC050229-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Methicillin Resistant Staphylococcus Aureus (MRSA) (332/423),CF405M conjugate, Concentration: 0.1mg/mL |